China Pharma Holdings, Inc.

US$0.57As of Sun 8 Nov 2026, 12:00 UTC
AMEX:CPHIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (40.15%)
Div yield —
ROE (20.99%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.96
PE TTM —
TSR TTM (65.25%)
Mkt cap US$24.52M
ROIC (10.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.637
11.84%
39.59%
Hold 10|2|2|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.02
0.02
29.14%
35.23%
41.46%
40.83%
Revenue$M
3.065
3.086
3.215
3.184
2.14%
(0.48%)
3.89%
0.80%
Peers (US$24.52M)
Cap (US$)
PE
24.68M
—
Capital
TTM
5Y
10Y
Leveragex
0.140
0.102
0.099
EBIT/Intx
1.147
0.903
0.905
Own earn%
35.99
0.60
(0.05)
Sh yield%
34.34
42.97
39.71
Owners
Insiders/Inst%
8.82
61.98
Short interest%
0.91
SBC / revenue%
5.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
22–30
$1 testx
−0.8
Incr. ROIC%
43